Stem cells therapy of Alzheimer’s disease. Patients’ reviews.

The best results of cell therapy are observed in the early stages of the development of Alzheimer's disease, therefore, when the first signs appear, you should consult a doctor. As a result of stem cell transplantation, the process of disintegration of brain neurons is suspended, and the development of the disease slows down or even stops for a while.  Discover more about stem cells therapy of autoimmune diseases: Autoimmune diseases and Stem cells therapy

But even in the later stages of the disease, the use of cell therapy can stabilize the patient's mental state and suspend the process memory impairment and deformation of intelligence.

We present one of the results of treatment for Alzheimer's disease as a clear example of improvement after therapy for 4 months , after the introduction of stem cells ( MSC of umbilical cord and hematopoietic, intravenous and lumbar into the spinal cord) Read more: Stem cell therapy for Alzheimer's disease

Stem cell therapy for Alzheimer’s disease is an emerging area of regenerative medicine that is being investigated as a potential approach to neurological disorders and age-related neurodegeneration. Individual patient cases and early clinical studies have described experiences in which patients receiving stem cell-based treatment showed changes in cognitive function, daily activities, general well-being, or neurological status during follow-up. These reports have increased interest in stem cell therapy for Alzheimer’s disease and the potential role of regenerative medicine in supporting patients with neurodegenerative conditions.

Some reported cases of stem cell treatment for Alzheimer’s disease have focused on the use of mesenchymal stem cells (MSCs), including umbilical cord-derived mesenchymal stem cells. Researchers are investigating whether these cells may influence neuroinflammation, immune responses, and the cellular environment of the brain through paracrine and immunomodulatory mechanisms. In individual cases, improvements or stabilization of certain clinical parameters have been reported after treatment, although such observations cannot establish that stem cell therapy was solely responsible for the outcome.

Patient experiences following regenerative treatment for Alzheimer’s disease can vary depending on disease stage, overall health, cognitive status, treatment protocol, and duration of follow-up. Some individual cases may describe improvements in memory-related functions, communication, daily activity, or quality of life, while other patients may experience stabilization rather than noticeable improvement. These patient stories can provide valuable insight into the potential of cell-based therapy for Alzheimer’s disease, but they should be interpreted as individual experiences rather than guaranteed treatment results.

The cases presented in this article illustrate the growing interest in stem cell therapy for Alzheimer’s disease, mesenchymal stem cell therapy, and regenerative medicine for neurodegenerative diseases. Although some individual patient experiences and early research findings are encouraging, stem cell treatment for Alzheimer’s disease remains an evolving field and is not established as a proven cure. Further controlled clinical research and long-term follow-up are needed to determine the safety, effectiveness, appropriate cell types, treatment protocols, and potential long-term benefits of regenerative cell therapy for Alzheimer’s disease.